PA2G4P3

Across TCGA pan-cancer cohorts, PA2G4P3 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of PA2G4P3’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where PA2G4P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types PA2G4P3 is over-expressed in tumor.

STAD and COAD are the cancer types where PA2G4P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PA2G4P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	+0.031	.003	3	view →
COAD	All	All	+0.023	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

PA2G4P3–STAD

Open the STAD breakdown →